Patterns of use and harms associated with non-medical ketamine use.
about
Use of ecstasy and other psychoactive substances among school-attending adolescents in Taiwan: national surveys 2004-2006Sit Down to Float: The Cultural Meaning of Ketamine Use in Hong KongFirst injection of ketamine among young injection drug users (IDUs) in three U.S. citiesLegal highs: staying on top of the flood of novel psychoactive substancesThe prevalence and natural history of urinary symptoms among recreational ketamine users.Longitudinal trajectories of ketamine use among young injection drug users.Ketamine use: a review.Street ketamine-associated bladder dysfunction: an emerging health problem.Phenomenon of new drugs on the Internet: the case of ketamine derivative methoxetamine.Prevalence of new psychoactive substances: A retrospective study in hair.Gender differences in subjective discontinuation symptoms associated with ketamine use.Acute toxicity associated with the recreational use of the novel dissociative psychoactive substance methoxphenidine.Ketamine and the next generation of antidepressants with a rapid onset of actionConcurrent use of methamphetamine, MDMA, LSD, ketamine, GHB, and flunitrazepam among American youthsThe epidemiology and patterns of acute and chronic toxicity associated with recreational ketamine useEnvironmental enrichment and abstinence attenuate ketamine-induced cardiac and renal toxicity.Patterns of polydrug use among ketamine injectors in New York CityIs off-label repeat prescription of ketamine as a rapid antidepressant safe? Controversies, ethical concerns, and legal implications.Ketamine-induced ventricular structural, sympathetic and electrophysiological remodelling: pathological consequences and protective effects of metoprolol.Party drugs: properties, prevalence, patterns, and problems.Recent trends in the use of "club drugs": an Australian review.Analysis of print news media framing of ketamine treatment in the United States and Canada from 2000 to 2015.Cystitis due to the use of ketamine as a recreational drug: a case reportChronic administration of ketamine for analgesia.GC-MS confirmation of xylazine (Rompun), a veterinary sedative, in exchanged needles.Towards an Explanation of Subjective Ketamine Experiences among Young Injection Drug Users.HIV Sexual Risk Behaviors among Ketamine and Non-Ketamine Using Criminal Offenders Prior to Prison EntryPolydrug use among club-going young adults recruited through time-space samplingPrescription drug misuse among club drug-using young adults.A 12-month naturalistic observation of three patients receiving repeat intravenous ketamine infusions for their treatment-resistant depression.Combinations of prescription drug misuse and illicit drugs among young adults.From "Special K" to "Special M": the evolution of the recreational use of ketamine and methoxetamine.Treatment of status epilepticus with ketamine, are we there yet?Ketamine: an update on its abuse.Nephrotoxic effects of designer drugs: synthetic is not better!Ketamine and international regulations.A REVIEW OF KETAMINE ABUSE AND DIVERSION.Ketamine-associated urinary tract dysfunction: an underrecognized clinical entity.Quantifying the psychological effects of ketamine: from euphoria to the k-Hole.Multiple drug use and polydrug use amongst homeless traveling youth.
P2860
Q21257199-13BB373E-A550-46D1-B6CA-3322A967301CQ24654253-048C3C39-A7BF-4B34-AB90-68D989EC0652Q24683265-6F00C5D9-3F29-4764-B0EC-AA8AE8FADEABQ26799231-B291677B-1FA5-4E02-9393-D6A81BB12A3AQ30414279-03B87104-C064-4E97-BBE9-D43878BA0078Q33932400-E4A9A799-9942-42C4-89D4-BA57570539E7Q34202404-DDFD96D0-3DAE-495B-9E40-33CAC077C999Q34220682-28E899BE-DC49-48D5-AFD3-FB612FCCA1D4Q34258539-495AFE89-252C-4FD7-AA26-BBF67D0FA2C1Q34270004-45D88417-F953-468B-991F-32AE0CF85A91Q34283302-946D4BFC-ABFB-45DB-B497-2FFB47871259Q34445226-D313EC8D-ABEB-41C4-BDE6-682B09DAD6A8Q34978041-16B1FB25-040A-4932-8311-4E0073241C63Q35090740-082963A9-EC81-4F7D-9963-4369BCE0E991Q35200052-0C46DD0C-D013-416B-9D7A-E526F493321EQ35783675-1C34AD2F-8B2C-4829-9777-258E45DF9C48Q35854920-CC9F1E8C-BBB3-4BC4-B025-287C884F1259Q35894579-A3D0C001-F730-4759-9281-C6D4278559EAQ36025342-0F528BDF-213D-43B6-B0EC-E91BE60866DEQ36209983-F9B75B90-55A7-4A47-A752-7414C871FA0BQ36209990-33CD3715-4546-4A5A-A379-4E86D1FE2819Q36296872-891A5ACD-2B2B-477B-B4E9-BC144C4BF746Q36743832-B8EF333B-7C32-4D49-BE41-1C5E9CE9CABEQ36790314-04413D70-E8E0-497D-9A48-115B5DB9B40EQ36857686-FF2BE495-5779-476F-8B66-C5C797EDFEC7Q36940368-CB85F155-A5CB-4E3B-BF7D-315AE9A49053Q37126025-43E8F9C2-9B61-4293-9C35-786F0E9F306BQ37195424-F7A3D76C-9A84-4310-B303-6E49C84215A8Q37382872-73EBDEBB-A0E5-407A-BB66-FE7909E10229Q37639101-987C4770-63B6-4573-8E14-3C529386CEA4Q37692744-C6E1E28A-F780-44B3-95B7-64EA2642AD96Q38082838-883A9895-3588-441E-9D65-7802C11B965AQ38100382-3A3FB9C4-73D7-454F-A02C-9A80DC4EF495Q38197894-4F1984A1-5BEE-4238-B9E7-7EC8D411BC82Q38198873-6A2F7C11-31E2-4E3E-BA12-DF69F6F07438Q38370198-F7DE3729-C451-4E51-BEF9-C8BEFCFE712AQ38872263-A3896EF6-5E71-44B0-A731-F74482E6E0EEQ39246120-4E1DF769-72CD-4A10-B182-096E5B9A0A8EQ42840560-ADC82BB5-DB53-4193-B927-B29276A5D431Q43258393-7B3C0F3E-3AF6-4E34-8391-2B820C11A1B1
P2860
Patterns of use and harms associated with non-medical ketamine use.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Patterns of use and harms associated with non-medical ketamine use.
@en
Patterns of use and harms associated with non-medical ketamine use.
@nl
type
label
Patterns of use and harms associated with non-medical ketamine use.
@en
Patterns of use and harms associated with non-medical ketamine use.
@nl
prefLabel
Patterns of use and harms associated with non-medical ketamine use.
@en
Patterns of use and harms associated with non-medical ketamine use.
@nl
P2093
P1476
Patterns of use and harms associated with non-medical ketamine use.
@en
P2093
Jan Copeland
Karl Jansen
Paul Dillon
P356
10.1016/S0376-8716(02)00243-0
P577
2003-01-01T00:00:00Z